Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis <fc>C</fc> virus
Mechanism of action of interferon and ribavirin in treatment of hepatitis C | Nature
Chronic viral hepatitis C: management update | CMAJ
Mechanism of action of ribavirin on poliovirus 3D pol . (A) Base... | Download Scientific Diagram
Finally sofosbuvir: an oral anti-HCV drug with wide performance capabi | PGPM
Viruses | Free Full-Text | Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations
Figure 1 from Sofosbuvir and daclatasvir | Semantic Scholar
Ribavirin: How Does it Work and is it Still Needed? | Current Hepatology Reports
Sofosbuvir - an overview | ScienceDirect Topics
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic... - YouTube
Sofosbuvir (GS-7977) | HCV Inhibitor | MedChemExpress
Core Concepts - Extrahepatic Conditions Related to HCV infection - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvir - ScienceDirect
Sofosbuvir - Wikipedia
Mechanism of action of sofosbuvir (SOF) against HCV NS5B. (A)... | Download Scientific Diagram
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus. - Abstract - Europe PMC
Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Sofosbuvir metabolism. The drug is phosphorylated to its active form in... | Download Scientific Diagram
Sofosbuvir for treatment of chronic hepatitis C | Hepatology International
Viruses | Free Full-Text | Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
Biology | Free Full-Text | The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD
Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol | Scientific Reports
Population Pharmacokinetics of Sofosbuvir and Its Major Metabolite (GS-331007) in Healthy and HCV-Infected Adult Subjects
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
